Access to Breast Cancer Diagnosis Act of 2019

United States116th CongressHR-2428House of Representatives
Updated: May 2, 2019

Summary

Access to Breast Cancer Diagnosis Act of 2019 This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-3216: Access to Breast Cancer Diagnosis Act of 2020

Introduced in Senate

  1. Referred to the House Committee on Energy and Commerce.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

All available records shown.